As highlighted in my pervious article Sigma Pharmaceutical: Taking its medicine: Sigma Healthcare (ASX:SIG) have inked a 5-year deal (starting July 1st, 2024) with Chemist Wearhouse to continue and increase supply FMCG and PBS products and medicines, and is expected to generate $3bn in sales in its first. The deal involves a placement of 126.9m shares to Chemist Wearhouse and affords the right to Chemist Wearhouse to acquire non-core assets of SIG, valued at $24.5m. As the supply agreement is due to start on 1st July 2024, SIG FY24 guidance remains unchanged. SIG shares are up 20% to 76c at the time of writing.
About the Author
Anton Crabbe
Hi my name is Anton and I have been investing in shares for over 10-years. I have completed a Masters of Applied Finance and worked in the share investment world for a period and this is where I met Elio and Chris and found my way to Stockopedia. I have a long-term fundamental investment approach which is heavily driven by ratio analysis. For me, ratio analysis cuts through the hyperverbal out there by the investment media, and the endless investment fads and flavour of the month stock. As such I mainly focus on Quality and Value; but since I have started using Stockopedia, I have started to incorporate more Momentum factors into my stock analysis. Outside of investing you will find me playing a bit of cricket and golf, or out doing a spot of fishing. more »
0 comments
